We are live on ! Find out more
MXIM

Maxim Integrated Products
MXIM

Delisted

MXIM was delisted on the 25th of August, 2021.

0 hedge funds and large institutions have $0 invested in Maxim Integrated Products in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 30 (-3)

100% less capital invested

Capital invested by funds: $1.53M → $0 (-$1.53M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
Holders Change
-3
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
1
Coldstream Capital Management
Washington
-$1.06M -15,733 Closed
RP
2
Rowlandmiller & Partners
Georgia
-$447K -7,370 Closed
TAIM
3
TD Ameritrade Investment Management
Nebraska
-$18K -266 Closed

MXIM Hedge Fund Activity: Q4 2021 in Review

0 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Maxim Integrated Products (MXIM) for Q4 2021, worth a combined $0 — down 100% from $1.53M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of MXIM and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Coldstream Capital Management, exiting entirely with an estimated $1.06M sold.

  • 0 institutional investors held Maxim Integrated Products (MXIM) as of Q4 2021, down from 3 in Q3 2021.
  • Funds reported $0 of Maxim Integrated Products stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Maxim Integrated Products positions in Q4 2021 and 3 closed out, a net change of -3 holders.
  • The largest Maxim Integrated Products seller in Q4 2021 was Coldstream Capital Management, an estimated $1.06M sold.

Based on aggregated 13F filings for Q4 2021.